YETER, H. H. Et Al. 2022. Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome. ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , vol.60, no.1 , 56-65.

YETER, H. H., DERİCİ, Ü., ARINSOY, S. T., ALTOK, K., ERTEN, Y., & GÜZ, G., (2022). Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome. ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , vol.60, no.1, 56-65.

YETER, HACI Et Al. "Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome," ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , vol.60, no.1, 56-65, 2022

YETER, HACI H. Et Al. "Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome." ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , vol.60, no.1, pp.56-65, 2022

YETER, H. H. Et Al. (2022) . "Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome." ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , vol.60, no.1, pp.56-65.

@article{article, author={HACI HASAN YETER Et Al. }, title={Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome}, journal={ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE}, year=2022, pages={56-65} }